Assay News and Research

RSS
Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

Novaplex real-time PCR assays can reliably, rapidly detect SARS-CoV-2 in patient samples

31 Mar 2022
Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

31 Mar 2022
Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

31 Mar 2022
Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

30 Mar 2022
Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

Chemical in leafy greens could prevent infections by coronaviruses including SARS-CoV-2

30 Mar 2022
Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

Study analyzed several naturally-occurring amino acid variations found in the extended loop harboring the SARS-CoV-2 S1/S2 cleavage site

30 Mar 2022
Antiviral functions of interferon regulatory factors during human coronavirus infection

Antiviral functions of interferon regulatory factors during human coronavirus infection

30 Mar 2022
Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

Divalent SARS-CoV-2 fusion vaccine found to be effective in mice

30 Mar 2022
Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

Preclinical investigation of intranasal adjuvanted COVID-19 vaccine

30 Mar 2022
Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

Engineering rotavirus-based vaccine vectors expressing SARS-CoV-2 spike epitopes

30 Mar 2022
A ferritin nanoparticle candidate vaccine for COVID

A ferritin nanoparticle candidate vaccine for COVID

30 Mar 2022
Utilizing AI to Accelerate the Field of High Content Analysis

Utilizing AI to Accelerate the Field of High Content Analysis

From Society for Laboratory Automation and Screening (SLAS) 29 Mar 2022
Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

29 Mar 2022
Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

29 Mar 2022
Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

28 Mar 2022
Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

28 Mar 2022
SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

27 Mar 2022
Clinical determinants of post-COVID-19 thromboembolism

Clinical determinants of post-COVID-19 thromboembolism

27 Mar 2022
Researchers quantify salivary inflammatory mediators in COVID-19

Researchers quantify salivary inflammatory mediators in COVID-19

27 Mar 2022
Evusheld™ found to poorly neutralize Omicron in kidney transplant patients

Evusheld™ found to poorly neutralize Omicron in kidney transplant patients

25 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback